Besides MLH1, men carrying mutations of other DNA mismatch repair (MMR) genes, including MSH2, MSH6, and PMS2, were also found to have an increased risk of prostate cancer (RR 3.67, 95% CI 2.32–6.67) in a meta‐analysis.20 Here, PMS2 is linked to prostate carcinoma.